ECM
AGN

ExodusPoint Capital Management’s Allergan plc AGN Stock Holding History

ExodusPoint Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,834
Closed -$325K – 2153
2020
Q1 		$325K Buy
+1,834
New +$345K 0.02% 629
2019
Q2 		– Sell
-2,882
Closed -$422K – 1439
2019
Q1 		$422K Buy
+2,882
New +$418K 0.03% 376

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

ExodusPoint Capital Management's AGN Position: Q2 2020 in Review

ExodusPoint Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,834 shares — an estimated $325K sold.

ExodusPoint Capital Management first reported a position in AGN in Q1 2019 and held it in 2 quarters. The position peaked at $422K in Q1 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • ExodusPoint Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • ExodusPoint Capital Management sold 1,834 Allergan plc shares in Q2 2020, an estimated $325K.
  • ExodusPoint Capital Management first reported a position in Allergan plc in Q1 2019 and held it in 2 quarters.
  • ExodusPoint Capital Management's Allergan plc position peaked at $422K in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on ExodusPoint Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.